No Data
No Data
NRx Pharmaceuticals Added to Emerging Growth Conference 76 on October 31 and Update to Schedule
NRx Pharmaceuticals Unit Signs Letter of Intent to Buy Clinics in Florida; Shares Rise
HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announce Signing of a Letter of Intent to Acquire Its First Florida Interventional Psychiatry Clinics
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) and HOPE Therapeutics, Inc. Announce Participation at the ThinkEquity Conference October 30, 2024
NRx Started at Buy by EF Hutton, Cites Focus on Suicide Prevention
Express News | EF Hutton Initiates Coverage On NRX Pharmaceuticals With Buy Rating, Announces Price Target of $31
No Data
No Data